Experience

Debiopharm

• Switzerland
• Pharmaceutical Manufacturing
• 300 - 400 Employee

• Principal Clinical Scientist

  • Jul 2022 - Present

• Senior Clinical Scientist

  • Feb 2019 - Jun 2022



ImmunoBiology Ltd

• Biotechnology Research

• Development Director

  • Nov 2017 - Jan 2019



Prokarium

• United Kingdom
• Biotechnology Research
• 1 - 100 Employee

• Head of Operations

  • Mar 2016 - Oct 2017

• Operations Manager

  • Jan 2015 - Feb 2016



MEDEURONET (UK) LIMITED

• United Kingdom
• Pharmaceutical Manufacturing

• Clinical Scientist

  • May 2014 - Dec 2014



Freelance Clinical Project Manager/ Consultant

• Freelance Clinical Project Manager/ Consultant

  • Apr 2013 - Apr 2014

  Providing clinical operations and medical writing support to pharmaceutical and biotech companies Providing clinical operations and medical writing support to pharmaceutical and biotech companies



Helperby Therapeutics

• United Kingdom
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Clinical Director

  • Mar 2010 - Mar 2013

  • Managing Helperby’s clinical studies including study protocols preparation, CTA submissions, company point of contact, contract negotiations and total responsibility for delivering all clinical studies.• Selection of suitable CROs/sites to conduct clinical and preclinical studies.• Contributing to Helperby’s dossiers submitted to the MHRA and EMA, which resulted in the EMA issuing draft guidelines for a 30 day microbiological endpoint for decolonisation of the nose for Staphylococcus aureus.• Core Management Team- assist with daily activities of running the company.• Assisting in the set-up of the Helperby quality system and preparing for Helperby’s first MHRA inspection as the main responsible person.• Coordinating and monitoring the operations of the company’s contractors and service providers as primary contact point, and ensuring good relations between the company and the contractors and service providers• Coordinator and main contributor for European Commission FP7 application. • Contributor/ co-writer to several national and international (EC/FP7, NIH) grant applications. Show less

• Clinical Study Manager

  • Dec 2007 - Feb 2010

  • Clinical study monitor for Helperby’s first Phase II study.• Clinical Study Manager for ANTIRESDEV, a multicentre, Phase IV study funded by European Commission’s FP7 programme.• Quality control and sponsor oversight of on-going clinical trials• Co-author of the company’s Information Memorandum• Responsibility for writing the company’s first standard operating procedures.

• Clinical Trial Manager, Lead Scientist

  • Apr 2006 - Nov 2007

  • Design of research projects• Responsibility for microbiological and cell biological assays to study the mode of action of Helperby’s major drug candidates. • Set up of electron microscopy experiment to study interaction of Helperby’s drug candidates with bacterial cell. These works lead to the first publication about the mode of actions of Helperby’s drug candidates.



UCL

• United Kingdom
• Research Services
• 700 & Above Employee

• Researcher Fellow

  • 2003 - 2006



Imperial College London

• Research Services
• 700 & Above Employee

• Research Fellow

  • 2001 - 2003



Karolinska Institutet

• Sweden
• Higher Education
• 700 & Above Employee

• Post Doctoral Fellow

  • Dec 2000 - Oct 2001